NCT03545191: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT03545191 |
---|---|
Title | Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | June 4, 2018 |
Completion date | Jan. 25, 2020 |
Required reporting date | Jan. 25, 2023, midnight |
Actual reporting date | Jan. 7, 2022 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |